Lucas Svetlana
SEC CIK 1781292 · EDGAR
BoughtSold
Most active insiders at SCTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aghazadeh Behzad | Dir, 10%, See Remarks | $36.26M | — |
| 2 | GORDON CARL L | Dir | $15.00M | — |
| 3 | ORBIMED ADVISORS LLC | Dir | $15.00M | — |
| 4 | AH Bio Fund II, L.P. | 10% | $5.00M | — |
| 5 | Lucas Svetlana | Chief Business Off | $45.0K | — |
| 6 | Parrot David | CFO | $40.0K | — |
| 7 | Doudna Jennifer A | 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-07-27 21:42 | 2026-07-23 | SCTX | Scribe Therapeutics, Inc. | Lucas Svetlana | Chief Business Off | P - Purchase | $15.00 | +3,000 | 3,000 | New | +$45.0K |
| D | 2025-09-24 | 2025-09-22 | JSPR | Jasper Therapeutics, Inc. | Lucas Svetlana | Dir | P - Purchase | $2.43 | +20.0K | 20.0K | New | +$48.6K |
| D | 2023-04-28 | 2023-04-26 | ATYR | aTYR PHARMA INC | Lucas Svetlana | Dir | M - OptEx | — | +6,000 | 6,000 | New | — |
Purchase Sale Sale after option exercise All abbreviations